Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - TOTAL CURRENT LIABILITIES
Total Current Liabilities HALO - Halozyme Therapeutics, Inc.
112 M
LAST VALUE
-2.01%
2 YEAR CAGR
-5.51%
5 YEAR CAGR
16.02%
10 YEAR CAGR